Patents by Inventor Michael Schliack

Michael Schliack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of droloxifene for the treatment of cardiovascular disease
    Patent number: 5902830
    Abstract: Use of droloxifene in the treatment of cardiovascular diseases.
    Type: Grant
    Filed: March 26, 1998
    Date of Patent: May 11, 1999
    Assignee: Pfizer Inc.
    Inventors: Roland Loser, Michael Schliack, David D. Thompson
  • Use of droloxifene for the treatment of cardiovascular diseases
    Patent number: 5827892
    Abstract: Use of droloxifene in the treatment of cardiovascular diseases.
    Type: Grant
    Filed: March 13, 1996
    Date of Patent: October 27, 1998
    Assignee: Pfizer Inc.
    Inventors: Roland Loser, Michael Schliack, David D. Thompson
  • p-Oxybenzoic acid derivatives, process for the preparation thereof and use thereof as drug
    Patent number: 5153353
    Abstract: p-Oxybenzoic acid derivatives of the general formula (1) ##STR1## their physiologically compatible salts and their enantiomeric and diastereomeric forms have hypolipemic properties and are therefore suitable for the preparation of drugs with hypolipemic action.
    Type: Grant
    Filed: August 8, 1991
    Date of Patent: October 6, 1992
    Assignee: Klinge Pharma GmbH
    Inventors: Friedemann Reiter, Peter Jank, Michael Schliack, Kaisli Kaipainen-Reiter, Gerhard Lang, Anke Schink
  • New p-oxibenzoic acid derivatives, process for their preparation and their use as drug
    Patent number: 5149865
    Abstract: The invention relates to p-oxibenzoic acid derivatives of the general formula (1) where: ##STR1## their diastereomers and enantiomers in pure form or as mixture of stereoisomeric forms and their physiologically compatible salts, a process for the preparation thereof and the use thereof for preparing drugs with hypolipemic effect.
    Type: Grant
    Filed: December 20, 1991
    Date of Patent: September 22, 1992
    Assignee: Klinge Pharma GmbH
    Inventors: Friedemann Reiter, Helmut Grill, Hans-Helmut Henschel, Michael Schliack, Klaus Seibel, Roland Loser, Gerhard Lang
  • New benzoic acid derivatives, as well as processes for their production and their use as pharmaceuticals
    Patent number: 4778925
    Abstract: Para substituted benzoic acid derivatives of general formula (1) ##STR1## and their physiologically compatible salts, where R.sup.1 may be H, isopropyl, t-butyl p0 X may be ##STR2## and R.sup.2 may be --OH, --OR', where R' is a linear or branched, saturated or unsaturated C.sub.1 to C.sub.3 alkylmoiety, or a --NHCH.sub.2 COOH-- group, have hypolipedemic activity. They may be obtained by known methods either from the corresponding unsaturated ketones or from saturated hydroxycompounds, where the esterified benzoic acid moiety may be saponified or converted to a carboxymethylamide.
    Type: Grant
    Filed: May 22, 1987
    Date of Patent: October 18, 1988
    Assignee: Klinge Pharma GmbH
    Inventors: Helmut Grill, Friedemann Reiter, Michael Schliack, Roland Loser, Klaus Seibel
  • Novel p-oxybenzoic acid derivatives, processes for their production and their use as drugs
    Patent number: 4582857
    Abstract: P-oxybenzoic acid derivatives of formula (1) ##STR1## wherein R.sup.1 is hydrogen, or straight or branched alkyl of one to four carbon atoms;n is 1 or 2;X is ##STR2## and R.sup.2 is --OH or --NHCH.sub.2 COOH; and non-toxic pharmaceutically acceptable salts thereof.The compounds exhibit a hypolipemic effect. They may be prepared by methods known in themselves from the corresponding ester or acid halide compounds, wherein optionally the secondary alcohol group may be oxidized to a keto group.
    Type: Grant
    Filed: July 20, 1984
    Date of Patent: April 15, 1986
    Assignee: Klinge Pharma GmbH
    Inventors: Helmut Grill, Friedemann Reiter, Roland Loser, Michael Schliack, Klaus Seibel